BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2751599)

  • 1. Clinical aspects of neutron capture therapy. Proceedings of a workshop. February 1-2, 1988, Upton, New York.
    Basic Life Sci; 1989; 50():1-370. PubMed ID: 2751599
    [No Abstract]   [Full Text] [Related]  

  • 2. [Boron neutron capture a a new radiotherapy model].
    Hideghéty K; Sauerwwein W; Rassuw J; Sack H
    Orv Hetil; 1998 Mar; 139(12):675-9. PubMed ID: 9555163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New compounds for neutron capture therapy (NCT) and their significance.
    Fairchild RG; Bond VP
    Strahlentherapie; 1984 Dec; 160(12):764-70. PubMed ID: 6393459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy for cancer.
    Barth RF; Soloway AH; Fairchild RG
    Sci Am; 1990 Oct; 263(4):100-3, 106-7. PubMed ID: 2173134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective affinity of 10B1-paraboronophenylalanine-HCl to malignant melanoma: thermal neutron capture therapy].
    Tsuji M; Ichihashi M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1983 Jun; 93(7):773-8. PubMed ID: 6620640
    [No Abstract]   [Full Text] [Related]  

  • 6. [Boron delivery system for neutron capture therapy of cancer].
    Nakamura H
    Rinsho Ketsueki; 2008 May; 49(5):294-301. PubMed ID: 18572805
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of dimercaptocarborane derivatives in neutron capture therapy].
    Spryshkova RA; Bratsev VA; Shabalkin IP
    Med Radiol (Mosk); 1980 Nov; 25(11):46-50. PubMed ID: 7442488
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutron beam design, development, and performance for neutron capture therapy. Proceedings of an international symposium. March 29-31, 1989, Cambridge, Massachusetts.
    Basic Life Sci; 1990; 54():1-353. PubMed ID: 1980058
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry.
    Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Okabe M; Kirihata M; Ono K; Kuroiwa T
    Radiat Res; 2007 Jan; 167(1):102-9. PubMed ID: 17214510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approach to incorporation of boron in tumor-seeking molecules.
    Sivaev IB; Semioshkin AA; Bregadze VI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S91-3. PubMed ID: 19375335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose rate and therapeutic gain.
    Fairchild RG
    Basic Life Sci; 1989; 50():1-7. PubMed ID: 2751600
    [No Abstract]   [Full Text] [Related]  

  • 12. Boronated compounds for neutron capture therapy.
    Alam F; Bapat BV; Soloway AH; Barth RF; Mafune N; Adams DM
    Strahlenther Onkol; 1989; 165(2-3):121-3. PubMed ID: 2494714
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiobiological considerations concerning the development of compounds for boron neutron capture therapy.
    Gabel D
    Strahlenther Onkol; 1993 Jan; 169(1):65-70. PubMed ID: 8434342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neutron capturing irradiation: principle, current results and perspectives].
    Pignol JP; Chauvel P
    Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001.
    Wittig A; Collette L; Moss R; Sauerwein WA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S59-62. PubMed ID: 19372041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accumulation of carborane-series compounds in animal tissues during neutron-capture therapy].
    Spryshkova RA; Brattsev VA; Sherman TL; Stanko VI
    Med Radiol (Mosk); 1981 Jul; 26(7):51-5. PubMed ID: 7289807
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
    Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
    Clin Cancer Res; 2000 Feb; 6(2):725-30. PubMed ID: 10690559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
    Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.